The therapeutic role of naltrexone in negative symptom schizophrenia

1. 1. Naltrexone (50 mg bid, p.o.) was administered in a double-blind fashion (with placebo control) to chronic schizophrenic patients who maintained their routine neuroleptic and anxiolytic therapy. 2. 2. Both positive and negative symptom patients who received naltrexone improved with regard to sy...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Progress in neuro-psychopharmacology & biological psychiatry 1995-12, Vol.19 (8), p.1239-1249
Hauptverfasser:	Marchesi, Gian Franco, Santone, Giovanni, Cotani, Paolo, Giordano, Antonio, Chelli, Francesco
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Antipsychotic Agents - therapeutic use Biological and medical sciences Chronic Disease Double-Blind Method Drug Therapy, Combination Female Humans Male Medical sciences Middle Aged naltrexone Naltrexone - therapeutic use Narcotic Antagonists - therapeutic use Neuropharmacology opioid peptides Pharmacology. Drug treatments Psychiatric Status Rating Scales Psycholeptics: tranquillizer, neuroleptic Psychology. Psychoanalysis. Psychiatry Psychopharmacology schizophrenia Schizophrenia - drug therapy Schizophrenic Psychology Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!